OKB’de SSRI Dozlaması: FDA Kılavuzlarının Ötesinde

View at publisher Summarise with VIRAT
Authors: Robert Hudak
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

A therapeutic trial for OCD requires maintaining the maximum SSRI dose for at least 12 to 16 weeks. Avoid augmentation strategies during this period. Effective OCD treatment can require SSRI doses above FDA maximum guidelines. These higher doses are evidence-based and safe. Citalopram is not recommended for OCD because its black box warning limits the maximum dosage required for anti-obsessional efficacy.

Fields of Study & Subjects

Obsessive-Compulsive Spectrum Disorders Anxiety Depression Psychometrics Treatment Cognitive Processes Treatment of Major Depression

Publication details

Publication date
1 February 2026
Language
EN